Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease

By Happe Svenja   Baier Paul   Helmschmied Kathrin   Meller Johannes   Tatsch Klaus   Paulus Walter  

Journal of Neurology, Vol. 254, Iss. 8, 2007-08 ,pp. : 1037-1043

Springer Publishing Company

Access to resources Recommend Favorite

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

By Bohnen Nicolaas   Gedela Satyanarayana   Kuwabara Hiroto   Constantine Gregory   Mathis Chester   Studenski Stephanie   Moore Robert  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

Gait variability in Parkinson’s disease: influence of walking speed and dopaminergic treatment

By Bryant Mon S   Rintala Diana H   Hou Jyhgong G   Charness Ann L   Fernandez Angel L   Collins Robert L   Baker Jeff   Lai Eugene C   Protas Elizabeth J  

Neurological Research, Vol. 33, Iss. 9, 2011-11 ,pp. : 959-964

Maney Publishing

Access to resources Recommend Favorite

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

By Cordellini Marcela   Piazzetta Giovana   Pinto Karin   Delattre Ana   Matheussi Francesca   Carolino Ruither   Szawka Raphael   Anselmo-Franci Janete   Ferraz Anete  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite